Did Christopher Jacobs sell Acadia Pharmaceuticals stock?

Common questions

Did Christopher Jacobs sell Acadia Pharmaceuticals stock?

Yes. Christopher Jacobs disclosed 2 sales of Acadia Pharmaceuticals (ACAD) stock between Sep 8, 2020 and Jun 16, 2022, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.

How big were Christopher Jacobs's Acadia Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.

Did Christopher Jacobs make these Acadia Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Christopher Jacobs still own Acadia Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Christopher Jacobs report these trades?

The latest filing is dated Jul 28, 2022. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.